Oral VK2735
Oral VK2735 for Weight Management Phase 3 (SUNRISE 1)
Viking Therapeutics · Phase 3 · Not yet recruiting · Enrollment 560
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Oral VK2735
Viking Therapeutics · Phase 3 · Not yet recruiting · Enrollment 560
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.